Comparison of the combination and quinolone therapy in community acquired pneumonia

Soylar O. K., KILINÇ O., ELLİDOKUZ H.

TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, cilt.63, sa.3, ss.165-169, 2015 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 63 Sayı: 3
  • Basım Tarihi: 2015
  • Doi Numarası: 10.5578/tt.9324
  • Dergi Adı: TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.165-169
  • Anahtar Kelimeler: Pneumonia, drug therapy, combination, fluoroquinolones
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Introduction: Objective of this study is to compare the difference between the length of hospitalisation, cost of treatment and treatment outcome of patients diagnosed with community acquired pneumonia and treated with beta-lactam-macrolide combination or fluoroquinolone monotherapy, according to 2009 Turkish Thoracic Society (TTS) Guide of Diagnosis and Treatment of Community Acquired Pneumonia in Adults (TTSCAPG).